Will Urban-Smith will start as VP within HBC’s Consumer Health Division from February 2021.
Mr Urban-Smith is an innovative commercial leader within consumer healthcare and FMCG and joins HBC after more than 15 years at Johnson & Johnson (J&J), where he has held various senior leadership positions across sales & customer management, commercial strategy, and revenue growth.
Mr Urban-Smith’s addition follows the recent hiring of Andy Gill (LENKE)
In his most recent role as Sales Director, Urban-Smith was responsible for building J&J’s strategic relationships with key UK and global customers to drive long-term value, leading to the development of channel growth strategies, new distributor agreements and B2B e-commerce platforms.
Will Urban-Smith says: “This a fantastic opportunity and I am excited to be joining the team as we embark on a journey to bring the medicine of tomorrow to customers and consumers around the world. I believe HBC is in an enviable position of being able to combine sustainable, science-based production capability with a differentiated portfolio that can enhance global health, and I want to play a key role in helping them unlock this huge growth potential.”
Mr Urban-Smith has worked closely on brand development and growth strategies for some of J&J’s largest global brands such as Johnson’s Baby, Aveeno, Listerine, Neutrogena and Nicorette.
“The fact HBC is now in the position to attract this kind of talent and experience from the leading pharma companies is testament to the HBC sustainability story and all the millions of dollars invested in R&D over the years. Leading healthcare and FMCG companies and professionals alike are starting to understand just how differentiated our clean, sustainable marine by-products are and the scale of the opportunity.”, says CEO Roger Hofseth of Hofseth BioCare.